Top Qs
Timeline
Chat
Perspective

Novacyt

Anglo-French biotechnology group From Wikipedia, the free encyclopedia

Novacyt
Remove ads

Novacyt Group (/ˈnvəst/ NOH-və-syte) is an Anglo-French biotechnology group focused on clinical diagnostics, with offices in Camberley, Surrey, United Kingdom and Vélizy-Villacoublay, France.[1][2] The company produces in vitro and molecular diagnostic tests, supplying assays and reagents worldwide.[3] Its business units include Primerdesign, Microgen Bioproducts and Lab21 Healthcare.[4]

Quick Facts Company type, Traded as ...

In January 2020 the company announced that its molecular diagnostics division, Primerdesign, had launched a molecular test for the 2019 strain of SARSr-CoV.[5][6][7][8] The test was approved as eligible for procurement under the World Health Organization's (WHO) Emergency Use Listing process in April 2020,[9] meaning that the test could be supplied by the United Nations and other procurement agencies supporting the COVID-19 response.[10] In the same month Novacyt announced a collaboration with AstraZeneca, GlaxoSmithKline and the University of Cambridge to support the UK in its COVID-19 national screening programme at a new testing laboratory at the university's Anne McLaren laboratory.[11][12]

Remove ads

References

Loading related searches...

Wikiwand - on

Seamless Wikipedia browsing. On steroids.

Remove ads